RottierBL, van ErpCJP, SluyterTS, HeijermanHGM, FrijlinkHW, de BoerAH. Changes in performance of the pari eFlow® rapid and pari LC plusTM during 6 months use by CF patients. J Aerosol Med Pulm Drug Deliv., 2009; 22:1–7
2.
MitchellJP, NagelMW, NicholsS, NerbrinkO. Laser diffractometry as a technique for rapid assessment of aerosol particle size from inhalers. J Aerosol Med., 2006; 19:409–433.
3.
BakuridzeL, AndrieuV, DupontC, DubusJC. Does repeated disinfection of the e-Flow rapid nebulizer affect in vitro performance?J Cyst Fibros., 2007; 6:309–10.
4.
RosenfeldM, EmersonJ, AstleyS, JoyP, Williams-WarrenJ, StandaertTA, YimDL, CristD, ThykkuttatihilM-J, TorrenceM, FitzSimmonsSC, RamseyBW. Home nebulizer use among patients with cystic fibrosis. J Pediatr., 1998; 132:125–131.
